FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2113249787> ?p ?o ?g. }

• W2113249787 endingPage "2058" @default.
• W2113249787 startingPage "2050" @default.
• W2113249787 abstract "Diffuse brainstem gliomas (BSGs) and other high-grade gliomas (HGGs) of childhood carry a dismal prognosis despite current treatments, and new therapies are needed. Having identified a series of glioma-associated antigens (GAAs) commonly overexpressed in pediatric gliomas, we initiated a pilot study of subcutaneous vaccinations with GAA epitope peptides in HLA-A2-positive children with newly diagnosed BSG and HGG.GAAs were EphA2, interleukin-13 receptor alpha 2 (IL-13Rα2), and survivin, and their peptide epitopes were emulsified in Montanide-ISA-51 and given every 3 weeks with intramuscular polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose for eight courses, followed by booster vaccinations every 6 weeks. Primary end points were safety and T-cell responses against vaccine-targeted GAA epitopes. Treatment response was evaluated clinically and by magnetic resonance imaging.Twenty-six children were enrolled, 14 with newly diagnosed BSG treated with irradiation and 12 with newly diagnosed BSG or HGG treated with irradiation and concurrent chemotherapy. No dose-limiting non-CNS toxicity was encountered. Five children had symptomatic pseudoprogression, which responded to dexamethasone and was associated with prolonged survival. Only two patients had progressive disease during the first two vaccine courses; 19 had stable disease, two had partial responses, one had a minor response, and two had prolonged disease-free status after surgery. Enzyme-linked immunosorbent spot analysis in 21 children showed positive anti-GAA immune responses in 13: to IL-13Rα2 in 10, EphA2 in 11, and survivin in three.GAA peptide vaccination in children with gliomas is generally well tolerated and has preliminary evidence of immunologic and clinical responses. Careful monitoring and management of pseudoprogression is essential." @default.
• W2113249787 created "2016-06-24" @default.
• W2113249787 creator A5002782232 @default.
• W2113249787 creator A5026029856 @default.
• W2113249787 creator A5026714103 @default.
• W2113249787 creator A5032059835 @default.
• W2113249787 creator A5050172772 @default.
• W2113249787 creator A5058793243 @default.
• W2113249787 creator A5065882309 @default.
• W2113249787 creator A5077770556 @default.
• W2113249787 creator A5080784534 @default.
• W2113249787 creator A5081032693 @default.
• W2113249787 date "2014-07-01" @default.
• W2113249787 modified "2023-10-18" @default.
• W2113249787 title "Antigen-Specific Immune Responses and Clinical Outcome After Vaccination With Glioma-Associated Antigen Peptides and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Children With Newly Diagnosed Malignant Brainstem and Nonbrainstem Gliomas" @default.
• W2113249787 cites W1989207092 @default.
• W2113249787 cites W2004150448 @default.
• W2113249787 cites W2005720265 @default.
• W2113249787 cites W2008171713 @default.
• W2113249787 cites W2014240672 @default.
• W2113249787 cites W2015653791 @default.
• W2113249787 cites W2016240186 @default.
• W2113249787 cites W2018658803 @default.
• W2113249787 cites W2024815986 @default.
• W2113249787 cites W2027570477 @default.
• W2113249787 cites W2030661519 @default.
• W2113249787 cites W2042708573 @default.
• W2113249787 cites W2060672294 @default.
• W2113249787 cites W2068958639 @default.
• W2113249787 cites W2069220906 @default.
• W2113249787 cites W2070323167 @default.
• W2113249787 cites W2071626601 @default.
• W2113249787 cites W2081027784 @default.
• W2113249787 cites W2094735628 @default.
• W2113249787 cites W2098263349 @default.
• W2113249787 cites W2104245348 @default.
• W2113249787 cites W2105758236 @default.
• W2113249787 cites W2106343920 @default.
• W2113249787 cites W2107733793 @default.
• W2113249787 cites W2110632746 @default.
• W2113249787 cites W2117735567 @default.
• W2113249787 cites W2123909650 @default.
• W2113249787 cites W2126432160 @default.
• W2113249787 cites W2126709464 @default.
• W2113249787 cites W2135811373 @default.
• W2113249787 cites W2137405984 @default.
• W2113249787 cites W2137605317 @default.
• W2113249787 cites W2143046187 @default.
• W2113249787 cites W2144182715 @default.
• W2113249787 cites W2144616410 @default.
• W2113249787 cites W2145755261 @default.
• W2113249787 cites W2151311897 @default.
• W2113249787 cites W2152043562 @default.
• W2113249787 cites W2154478576 @default.
• W2113249787 cites W2155367074 @default.
• W2113249787 cites W2155451340 @default.
• W2113249787 cites W2156301721 @default.
• W2113249787 cites W2156327992 @default.
• W2113249787 cites W2158233796 @default.
• W2113249787 cites W2162630386 @default.
• W2113249787 cites W2162746251 @default.
• W2113249787 cites W2164459955 @default.
• W2113249787 cites W2166112009 @default.
• W2113249787 cites W2166637991 @default.
• W2113249787 cites W2172048339 @default.
• W2113249787 cites W2341576311 @default.
• W2113249787 cites W2398280379 @default.
• W2113249787 cites W4252910285 @default.
• W2113249787 cites W57419024 @default.
• W2113249787 doi "https://doi.org/10.1200/jco.2013.54.0526" @default.
• W2113249787 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4067943" @default.
• W2113249787 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24888813" @default.
• W2113249787 hasPublicationYear "2014" @default.
• W2113249787 type Work @default.
• W2113249787 sameAs 2113249787 @default.
• W2113249787 citedByCount "157" @default.
• W2113249787 countsByYear W21132497872014 @default.
• W2113249787 countsByYear W21132497872015 @default.
• W2113249787 countsByYear W21132497872016 @default.
• W2113249787 countsByYear W21132497872017 @default.
• W2113249787 countsByYear W21132497872018 @default.
• W2113249787 countsByYear W21132497872019 @default.
• W2113249787 countsByYear W21132497872020 @default.
• W2113249787 countsByYear W21132497872021 @default.
• W2113249787 countsByYear W21132497872022 @default.
• W2113249787 countsByYear W21132497872023 @default.
• W2113249787 crossrefType "journal-article" @default.
• W2113249787 hasAuthorship W2113249787A5002782232 @default.
• W2113249787 hasAuthorship W2113249787A5026029856 @default.
• W2113249787 hasAuthorship W2113249787A5026714103 @default.
• W2113249787 hasAuthorship W2113249787A5032059835 @default.
• W2113249787 hasAuthorship W2113249787A5050172772 @default.
• W2113249787 hasAuthorship W2113249787A5058793243 @default.
• W2113249787 hasAuthorship W2113249787A5065882309 @default.
• W2113249787 hasAuthorship W2113249787A5077770556 @default.
• W2113249787 hasAuthorship W2113249787A5080784534 @default.
• W2113249787 hasAuthorship W2113249787A5081032693 @default.
• W2113249787 hasBestOaLocation W21132497872 @default.

• next